Invivyd, Inc.
Biotechnology company · New Haven, Connecticut, United States · Nasdaq: IVVD
Invivyd, Inc. is a biotechnology company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2020. Its shares trade on Nasdaq under the ticker IVVD. It has reported private securities offerings to the US SEC, most recently $24 million sold in a notice filed in 2022.
Invivyd at a glance
What does Invivyd do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $23.7 million sold (2022).
Frequently asked questions about Invivyd
Where is Invivyd headquartered?
Invivyd, Inc. is headquartered in New Haven, Connecticut, United States.
What does Invivyd do?
Invivyd, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Invivyd a public company?
Yes. Invivyd, Inc. trades on Nasdaq under the ticker IVVD.
When was Invivyd founded?
The earliest incorporation on record for Invivyd, Inc. is in 2020, according to public company registers.
Similar companies
- Allyx Therapeutics, Inc.New Haven, Connecticut, United States
- ReNetX Bio, Inc.New Haven, Connecticut, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.